Clinical Trials Directory

Trials / Unknown

UnknownNCT01384851

Efficacy of the Chronic Application of Tear Formulations

Therapeutic Efficacy of the Chronic Application of Tear Formulations for Dry Eye and Normal Subjects Under Conditions of Environmental Stress

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
38 (estimated)
Sponsor
Glasgow Caledonian University · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to determine the therapeutic effect of the chronic application of eye-drops on tear evaporation rate in dry eye and normal subjects exposed to a condition of environmental stress. The effect will be studied in terms of changes in tear physiology and the inflammatory biomarkers on the ocular surface.

Detailed description

Environmentally induced dry eye is a condition which occurs in otherwise asymptomatic individuals in certain situations, for example with the use of computers, in overheated or air conditioned workplaces and in conditions of low humidity. The most common ocular complaints associated with these environments are burning, dryness, stinging, and grittiness. Although the exact cause of these symptoms is unknown, it is thought that increased tear evaporation rate due to low humidity plays a vital role. The changes in tear film physiology, which occurs in these environments, have traditionally been dealt with by the use of eye drops (particularly the highly viscous variety), which have been shown to be an effective therapeutic option in the treatment of environmental dry eye disease. Previous studies of the use of eye-drops of various formulations has shown improvements in tear physiology in mild to moderate dry eye patients with their use in both acute and chronic application protocols. In this study, an attempt was made to relate the effects on tear physiology induced by variations in environmental conditions to the beneficial effect produced by the use of eye-drops.

Conditions

Interventions

TypeNameDescription
DRUGNext Generation EmulsionOne drop both eyes 4 times daily for two weeks
DRUGRefresh Dry Eye TherapyOne drop both eyes four times daily for two weeks
DRUGRefresh ContactsOne drop both eyes four times daily for two weeks

Timeline

Start date
2011-07-01
Primary completion
2011-11-01
Completion
2011-11-01
First posted
2011-06-29
Last updated
2011-07-01

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT01384851. Inclusion in this directory is not an endorsement.